DE69028951D1 - Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten Infektionen - Google Patents
Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten InfektionenInfo
- Publication number
- DE69028951D1 DE69028951D1 DE69028951T DE69028951T DE69028951D1 DE 69028951 D1 DE69028951 D1 DE 69028951D1 DE 69028951 T DE69028951 T DE 69028951T DE 69028951 T DE69028951 T DE 69028951T DE 69028951 D1 DE69028951 D1 DE 69028951D1
- Authority
- DE
- Germany
- Prior art keywords
- hiv
- viruses
- amplification
- oligonucleotide sequences
- infections caused
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- AIDS & HIV (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8907355A FR2647810B1 (fr) | 1989-06-02 | 1989-06-02 | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69028951D1 true DE69028951D1 (de) | 1996-11-28 |
DE69028951T2 DE69028951T2 (de) | 1997-05-07 |
Family
ID=9382332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69028951T Expired - Lifetime DE69028951T2 (de) | 1989-06-02 | 1990-06-05 | Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten Infektionen |
Country Status (11)
Country | Link |
---|---|
US (1) | US6020123A (de) |
EP (1) | EP0404625B1 (de) |
JP (1) | JPH04505558A (de) |
AT (1) | ATE144558T1 (de) |
CA (3) | CA2341946C (de) |
DE (1) | DE69028951T2 (de) |
DK (1) | DK0404625T3 (de) |
ES (1) | ES2095241T3 (de) |
FR (1) | FR2647810B1 (de) |
GR (1) | GR3022248T3 (de) |
WO (1) | WO1990015158A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2677039B1 (fr) * | 1991-05-31 | 1994-09-09 | Cis Bio Int | Oligonucleotides, utilisables comme reactifs pour la detection in vitro des infections a retrovirus de type hiv et procede de detection de retrovirus de type hiv. |
CN102134609A (zh) | 1994-10-20 | 2011-07-27 | 巴斯德研究所 | Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列 |
FR2731225B1 (fr) * | 1995-03-03 | 2003-10-31 | Pasteur Institut | Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique |
US5962665A (en) * | 1997-06-16 | 1999-10-05 | Abbott Laboratories | Nucleic acid primers and probes for detecting HIV-1 and HIV-2 |
US6001558A (en) * | 1997-06-25 | 1999-12-14 | Ortho Clinical Diagnostics, Inc. | Amplification and detection of HIV-1 and/or HIV 2 |
DE60132924T2 (de) | 2000-10-23 | 2009-03-05 | Gen-Probe Inc., San Diego | Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2) |
WO2003062377A2 (en) * | 2002-01-17 | 2003-07-31 | The Uab Research Foundation | COMPLETE GENOME SEQUENCE OF SIVcpzTAN1 |
CA2547750C (en) | 2003-12-19 | 2014-04-08 | Gen-Probe Incorporated | Compositions, methods and kits for detecting the nucleic acids of hiv-1 and hiv-2 |
US8747862B2 (en) | 2008-11-14 | 2014-06-10 | Tulane University Health Sciences Center | Pathogenic west african human immunodeficiency virus type 2 (HIV-2) group F isolate |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
CA2832109C (en) | 2011-06-10 | 2021-07-06 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
EP2679596B1 (de) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 Env-proteinvariante |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (de) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE64006B1 (en) * | 1984-10-18 | 1995-06-28 | Pasteur Institut | Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
AU606043B2 (en) * | 1985-03-28 | 1991-01-31 | F. Hoffmann-La Roche Ag | Detection of viruses by amplification and hybridization |
ES2150897T3 (es) * | 1986-01-22 | 2000-12-16 | Pasteur Institut | Procedimiento de fabricacion recombinante de las proteinas derivadas de hiv-2 y cultivo celular que expresa proteinas de hiv-2. |
US4839288A (en) * | 1986-01-22 | 1989-06-13 | Institut Pasteur | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
US5030714A (en) * | 1986-06-23 | 1991-07-09 | Institut Pasteur | Variant of LAV viruses |
ATE88762T1 (de) * | 1986-08-11 | 1993-05-15 | Siska Diagnostics Inc | Methoden und zusammensetzungen fuer tests mit nukleinsaeuresonden. |
US5079351A (en) * | 1986-11-26 | 1992-01-07 | Cetus Corporation | Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization |
ATE154808T1 (de) * | 1987-01-16 | 1997-07-15 | Pasteur Institut | Peptide mit den immunologischen eigenschaften von hiv-2 |
-
1989
- 1989-06-02 FR FR8907355A patent/FR2647810B1/fr not_active Expired - Lifetime
-
1990
- 1990-04-05 CA CA002341946A patent/CA2341946C/fr not_active Expired - Lifetime
- 1990-06-05 CA CA002592555A patent/CA2592555C/fr not_active Expired - Lifetime
- 1990-06-05 JP JP2509746A patent/JPH04505558A/ja active Pending
- 1990-06-05 WO PCT/FR1990/000394 patent/WO1990015158A1/fr active Application Filing
- 1990-06-05 EP EP90401521A patent/EP0404625B1/de not_active Expired - Lifetime
- 1990-06-05 DK DK90401521.1T patent/DK0404625T3/da active
- 1990-06-05 DE DE69028951T patent/DE69028951T2/de not_active Expired - Lifetime
- 1990-06-05 CA CA002055612A patent/CA2055612C/fr not_active Expired - Lifetime
- 1990-06-05 ES ES90401521T patent/ES2095241T3/es not_active Expired - Lifetime
- 1990-06-05 AT AT90401521T patent/ATE144558T1/de not_active IP Right Cessation
-
1994
- 1994-11-18 US US08/343,998 patent/US6020123A/en not_active Expired - Lifetime
-
1997
- 1997-01-09 GR GR970400012T patent/GR3022248T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0404625A2 (de) | 1990-12-27 |
GR3022248T3 (en) | 1997-04-30 |
CA2055612C (fr) | 2001-07-31 |
FR2647810B1 (fr) | 1994-07-22 |
WO1990015158A1 (fr) | 1990-12-13 |
CA2592555A1 (fr) | 1990-12-13 |
JPH04505558A (ja) | 1992-10-01 |
ES2095241T3 (es) | 1997-02-16 |
EP0404625A3 (de) | 1991-01-16 |
DK0404625T3 (da) | 1997-03-10 |
ATE144558T1 (de) | 1996-11-15 |
CA2341946A1 (fr) | 1990-12-13 |
CA2592555C (fr) | 2010-01-05 |
EP0404625B1 (de) | 1996-10-23 |
US6020123A (en) | 2000-02-01 |
CA2055612A1 (fr) | 1990-12-03 |
CA2341946C (fr) | 2007-10-23 |
DE69028951T2 (de) | 1997-05-07 |
FR2647810A1 (fr) | 1990-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1990015066A3 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus | |
DE69028951T2 (de) | Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten Infektionen | |
ATE315667T1 (de) | Amplifizierung und detektion von hiv-1 und/oder hiv-2 | |
ATE141946T1 (de) | Hiv-2-virusvarianten | |
ATE60800T1 (de) | Klonierte dns-sequenzen, hybridisierbar mit genom-rns vom ''lymphadenopathy-associated virus (lav)''. | |
DE3853422D1 (de) | HIV-3-Retrovirus und seine Verwendung. | |
ATE386821T1 (de) | Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2) | |
SG55095A1 (en) | Viruses and their use as a vaccine against feline infectious peritonitis virus disease | |
DK0831899T3 (da) | Rekombinant koppevirus-calicivirus-præparater og anvendelser | |
MX9700414A (es) | Agentes antivirales de difluoroestatona. | |
ATE121779T1 (de) | Nichtzurückschlagende rns-viren. | |
ATE212056T1 (de) | Methoden zur herstellung von rna viren aus cdna | |
ATE337404T1 (de) | Zur verleihung viraler resistenz an pflanzen geeignetes polyribozym und dieses polyribozym produzierende resistente pflanzen | |
DK76688A (da) | Vaccine indeholdende f-proteinet fra aids-virus | |
DE60035680D1 (de) | Komplette gensequenz des esel-leukozyten-impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung | |
FR2652091B1 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus. | |
FI893346A0 (fi) | Icke-reverterande rna-virus. | |
FI963073A (fi) | Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |